002626.SZ
Xiamen Kingdomway Group Co.
SZSE · Healthcare · C 制造业 · CN
CNY 18.10
+0.61%Price chart
Sep 23Sep 29Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30
Key dataOct 30, 2026
OpenCNY 17.50
From 52W high−16.24%
Volume10.36M
Market capCNY 11.04B
P/E (TTM)32.5x
P/S (TTM)3.2x
Div yield2.29%
Key dataOct 30, 2026
Open
CNY 17.50
From 52W high
−16.24%
Volume
10.36M
Market cap
CNY 11.04B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
17.3x
P/E (TTM)
32.5x
RSI (14)
54.6
MomentumView details →
1D Return
+0.61%
YTD Return
−11.21%
Similar companies
Latest newsMore news →
Kingdomway disclosed first-three-quarter 2026 revenue of 2.636 billion yuan, up 1.22% year over year, and attributable net profit of 254 million yuan, down 29.67%.4d agoKingdomway disclosed third-quarter 2026 revenue of 863 million yuan, down 1.46% year over year, and attributable net profit of 83.724 million yuan, down 26.25%.4d agoJindawei and its subsidiaries Inner Mongolia Jindawei Pharmaceutical and Jindawei Biotechnology (Jiangsu) received a Chinese invention patent for a chondroitin fermentation production control method from the National Intellectual Property Administration.31d ago